BenevolentAI Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$207.7M
Industry:Biotech
Founded:2013
Lead Investor(s):N/A

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • BenevolentAI's estimated annual revenue is currently $44.6M per year.
  • BenevolentAI received $115.0M in venture funding in April 2018.
  • BenevolentAI's estimated revenue per employee is $155,000
  • BenevolentAI's total funding is $207.7M.

Employee Data

  • BenevolentAI has 288 Employees.
  • BenevolentAI grew their employee count by 41% last year.
  • BenevolentAI currently has 9 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$46.5M300N/AN/A-N/A
#2
$29.1M188N/AN/A-N/A
#3
$16.7M108N/AN/A-N/A
#4
$35.7M230N/AN/A-N/A
#5
$26.8M173N/AN/A-N/A
#6
$58.9M380N/AN/A-N/A
#7
$20.2M130N/AN/A-N/A
#8
$23.7M153N/AN/A-N/A
#9
$21.7M140N/AN/A-N/A
#10
$24.8M160N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

BenevolentAI is the global leader in the development and application of artificial intelligence (AI) for scientific innovation. We aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world's 8,000 untreated diseases. Our team of technologists, AI researchers, and scientists builds and applies AI to the entire drug discovery and development process. The technology unlocks what is not known by creating new ideas based on established facts to provide a different understanding of disease, which leads to inventive steps and real insights that drive the development of new medicines and treatments. The goal To get the right treatments to the right patients at the right time *Reach out to us* Email: hello@benevolent.ai Careers: Careers@benevolent.ai Twitter: @benevolent_ai Website: benevolent.ai

keywords:N/A

288

Number of Employees

$44.6M

Revenue (est)

9

Current Jobs

41%

Employee Growth %

$207.7M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

BenevolentAI News

09/03/2019 - BenevolentAI and Novartis sign AI R&D deal

The Artificial Intelligence (AI)-based drug development firm BenevolentAI has signed an agreement with Novartis to find potential new uses for ...

09/08/2019 - BenevolentAI inks new collaboration deal with big pharma

BenevolentAI, a UK artificial intelligence (AI) company focused on health and drug development, has announced a new collaboration, with ...

09/03/2019 - Beyond the phenotype: using AI to better understand disease

Claus Bendtsen at AstraZeneca reveals how AI can be used to improve our understanding of disease, to help identify the causes of conditions ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A288142%N/A-N/A
#2
$101.7M28814%N/A-N/A
#3
$72.8M290N/AN/A-N/A
#4
$78.3M290N/AN/A-N/A
#5
$72.5M290N/AN/A-N/A

BenevolentAI Funding

DateAmountRoundLead InvestorsReference
2018-04-19$115.0MUndisclosedArticle

BenevolentAI Executive Hires

DateNameTitleReference
2018-05-03Joanna ShieldsGroup CEOArticle
2018-08-20Martin GouldstoneChief Business OfficerArticle